Olivier Civelli

Dr. Olivier Civelli


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2001 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
YSYumiko Saito
Yumiko Saito
MCMichelle Cheng
Michelle Cheng
FLFrances M. Leslie
Frances M. Leslie
OCOlivier Civelli
Olivier Civelli

23 December 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FJFrancois Jenck
Francois Jenck
JMJean-Luc Moreau
Jean-Luc Moreau
JMJames R. Martin
James R. Martin
GKGavin J. Kilpatrick
Gavin J. Kilpatrick
RRRainer K. Reinscheid
Rainer K. Reinscheid
OCOlivier Civelli
Olivier Civelli
Orphanin FQ (OFQ, Nociceptin) is a recently discovered 17-amino acid neuropeptide that is structurally related to the opioid peptides but does not bind opioid receptors. OFQ has been proposed to act as an anti-opioid peptide, but its widespread sites of action in the brain suggest that it may have more general functions. Here we show that OFQ plays an important role in higher brain functions because it can act as an anxiolytic to attenuate the behavioral inhibition of animals acutely exposed to stressful/anxiogenic environmental conditions. OFQ anxiolytic-like effects were consistent across several behavioral paradigms generating different types of anxiety states in animals (light-dark preference, elevated plus-maze, exploratory behavior of an unfamiliar environment, pharmacological anxiogenesis, operant conflict) and were observed at low nonsedating doses (0.1–3 nmol, intracerebroventricular). Like conventional anxiolytics, OFQ interfered with regular sensorimotor function at high doses (>3 nmol). Our results show that an important role of OFQ is to act as an endogenous regulator of acute anxiety responses. OFQ, probably in concert with other major neuropeptides, exerts a modulatory role on the central integration of stressful stimuli and, thereby, may modulate anxiety states generated by acute stress.

6 January 2013 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
OCOlivier Civelli
Olivier Civelli
RRRainer K. Reinscheid
Rainer K. Reinscheid
YZYan Zhang
Yan Zhang
ZWZhiwei Wang
Zhiwei Wang
RFRobert Fredriksson
Robert Fredriksson
HSHelgi Schiöth
Helgi Schiöth
G protein–coupled receptors (GPCRs) are major regulators of intercellular interactions. They initiate these actions by being activated by a wide variety of natural ligands. Historically, ligands were discovered first, but the advent of molecular biology reversed this trend. Most GPCRs are identified on the basis of their DNA sequences and thus are initially unmatched to known natural ligands. They are termed orphan GPCRs. Discovering their ligands—i.e., “deorphanizing” the GPCRs—gave birth to the field of reverse pharmacology. This review discusses the present status of GPCR deorphanization, presents a few examples of successes and surprises, and highlights difficulties encountered in these efforts.

21 April 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SCShinjae Chung
Shinjae Chung
FHF. Woodward Hopf
F. Woodward Hopf
HNHiroshi Nagasaki
Hiroshi Nagasaki
CLChun-Ying Li
Chun-Ying Li
JBJames D. Belluzzi
James D. Belluzzi
OCOlivier Civelli
Olivier Civelli
Drug addiction is mediated by complex neuronal processes that converge on the shell of the nucleus accumbens (NAcSh). The NAcSh receives inputs from the lateral hypothalamus (LH), where self-stimulation can be induced. Melanin-concentrating hormone (MCH) is produced mainly in the LH, and its receptor (MCH1R) is highly expressed in the NAcSh. We found that, in the NAcSh, MCH1R is coexpressed with dopamine receptors (D1R and D2R), and that MCH increases spike firing when both D1R and D2R are activated. Also, injecting MCH potentiates cocaine-induced hyperactivity in mice. Mice lacking MCH1R exhibit decreased cocaine-induced conditioned place preference, as well as cocaine sensitization. Using a specific MCH1R antagonist, we further show that acute blockade of the MCH system not only reduces cocaine self-administration, but also attenuates cue- and cocaine-induced reinstatement. Thus, the MCH system has an important modulatory role in cocaine reward and reinforcement by potentiating the dopaminergic system in the NAcSh, which may provide a new rationale for treating cocaine addiction.

1 April 2001 in Trends in Neurosciences
Verified
Journal Article
Closed access
OCOlivier Civelli
Olivier Civelli

1 January 2005 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
OCOlivier Civelli
Olivier Civelli